![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/valuestock_image_1291.jpeg)
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 9.78% on an annualized basis producing an average annual return of 19.75%. Currently, Novavax has a market capitalization of $3.69 billion.
Buying $100 In NVAX: If an investor had bought $100 of NVAX stock 5 years ago, it would be worth $238.79 today based on a price of $47.28 for NVAX at the time of writing.
Novavax's Performance Over Last 5 Years
![](https://www.benzinga.com/files/images/story/2022/1653402637_0.png)
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.